sb 203580 has been researched along with esculetin in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (esculetin) | Trials (esculetin) | Recent Studies (post-2010) (esculetin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 378 | 0 | 182 |
| Protein | Taxonomy | sb 203580 (IC50) | esculetin (IC50) |
|---|---|---|---|
| M17 leucyl aminopeptidase | Plasmodium falciparum 3D7 | 35.3 | |
| M18 aspartyl aminopeptidase | Plasmodium falciparum 3D7 | 44.19 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 48.2 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 8.2 | |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | 8.77 | |
| large T antigen | Betapolyomavirus macacae | 25.94 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YH; Kim, WJ; Moon, SK; Park, SS; Shin, HC; Yun, ES | 1 |
1 other study(ies) available for sb 203580 and esculetin
| Article | Year |
|---|---|
p38 MAPK activation is required for esculetin-induced inhibition of vascular smooth muscle cells proliferation.
Topics: Animals; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Imidazoles; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Umbelliferones; Up-Regulation | 2011 |